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Abstract
A combination of surface plasmon resonance (SPR) and matrix-assisted laser-desorption-
ionization-time-of-ﬂight mass spectrometry (MALDI-TOF-MS) was used to study the
interaction between endopolygalacturonase (PG) from Fusarium moniliforme and a
polygalacturonase-inhibiting protein (PGIP) from Phaseolus vulgaris. PG hydrolyses the
homogalacturonan of the plant cell wall and is considered an important pathogenicity
factor of many fungi. PGIP is a speciﬁc inhibitor of fungal PGs and is thought to be
involved in plant defence against phytopathogenic fungi. SPR was used either to study the
effect of the PG glycosylation on the formation of the complex with PGIP, and as a
sensitive afﬁnity capture of an interacting peptide from a mixture of PG fragments
obtained by limited proteolysis. Mass spectrometry allowed to characterise the interacting
peptide eluted from the sensor surface. Copyright # 2001 John Wiley & Sons, Ltd.
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Introduction
Surface plasmon resonance (SPR) biosensors are
important and versatile tools for studying protein–
protein interactions; they allow to measure interac-
tions in real time and require very little material,
which usually does not need any chemical modiﬁca-
tion. SPR technology coupled with mass spectro-
metry can be also used to identify and characterise
proteins eluted from sensor surfaces (So ¨nksen et al.,
2000; Williams, 2000). Once a sample containing a
mixture of possible ligands is passed over the sensor
surface, and binding is detected by the SPR signal,
the identiﬁcation of interacting proteins at the
femtomole level is made possible by the use of
sensitive mass spectrometers and advanced database
searching algorithms (Nelson et al., 2000).
We are studying the interaction between the
endopolygalacturonase (PG) from the phytopatho-
genic fungus Fusarium moniliforme with PGIP-2 of
Phaseolus vulgaris. PGs catalyse the fragmentation
and solubilisation of homogalacturonan in the plant
cell wall and play an important role during
pathogenesis. Polygalacturonase-inhibiting proteins
(PGIPs), present in the cell wall of many plants,
form speciﬁc complexes with fungal PGs and favour
the accumulation of oligogalacturonides able to
elicit plant defence responses (Cervone et al., 1997).
PGIPs belong to a super-family of leucine-rich
repeat (LRR) proteins. In a previous study, we
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Copyright # 2001 John Wiley & Sons, Ltd.showed that F. moniliforme polygalacturonase and
PGIP-2 speciﬁcally interact with high afﬁnity (KD=
47 nM), and we demonstrated that the residues in
the predicted b–strand/b–turn motif of PGIP are
critical for its afﬁnity and speciﬁcity for the PG
ligands (Leckie et al., 1999). The residues of PG
involved in the interaction with PGIP are still
unknown.
One of the best characterised members of the
LRR superfamily is ribonuclease inhibitor (RI),
that utilises a large set of interactions to achieve
tight binding to different members of the RNase
family (Kobe et al., 1996; Papageorgiou et al.,
1997).
In analogy with what is known for RI complexes,
it is likely that a network of contacts occur between
PG and PGIPs. The aim of this study was to gain
information on which domain of PG contains the
PGIP interacting residues and whether the glycosy-
lation of the PG molecule has any effect on the
interaction.
Materials and methods
Protein puriﬁcation
PGIP-2 was puriﬁed from Nicotiana benthamiana
plants infected with PVX as previously described
(Mattei et al., 2001).
FmPG expressed in yeast was prepared and
puriﬁed as previously described (Caprari et al.,
1996).
Surface plasmon resonance
The interaction between FmPG and immobilised
PGIP-2 was measured in real time by surface
plasmon resonance using BIACORE X2 equip-
ment (BIACORE AB, Uppsala, Sweden). Protein
interaction analyses were performed on research
grade BIACORE CM5 sensor chips. For the
immobilisation of PGIP-2 the sensor chip was
activated by injection of 35 ml of 1:1 mixture of
N-ethyl-Nk-(3-diethylaminopropyl)carbodiimide and
N-hydroxysuccinimide at 5 ml/min ﬂow rate. Run-
ning buffer used during the immobilisation proce-
dure was HBS (10 mM Hepes, pH 7.4, 150 mM
NaCl, 0.005% [v/v] surfactant P20 from BIA-
CORE, in distilled water). 40 ml of bean PGIP-2
at 100 ng/ml in 10 mM sodium acetate, pH 4.5,
were injected over the sensor chip, followed by
35 ml of 1 M ethanolamine hydrochloride to block
the remaining ester groups. A total of 4000–5000 RU
(Resonance Units, which are proportional to the
mass of protein bound on the surface of the chip) of
PGIP-2 were immobilised onto the sensor chip
surfaces, corresponding to a density of 4–5 ng/mm
2.
A second ﬂow-cell of the sensor chip was treated
in the same way, except that buffer was injected
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Figure 1. MALDI spectrum of a glycopeptide obtained by RP HPLC separation of the tryptic digest of FmPG. The peak at
m/z 1797.43 corresponds to the nonglycosylated form of the peptide spanning from amino acid 57 to amino acid 72,
containing a potential N-glycosylation site at Asn65. Up to 14 Man residues are present in the glycan chain
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reference ﬂow-cell. In the interaction assays, PG
solutions in 25 mM ammonium acetate buffer pH
5.0 were injected onto the PGIP-2 sensor chip at a
ﬂow rate of 5 ml/min.
Limited proteolysis of FmPG was performed by
incubating the native enzyme with Endoproteinase
Lys C (Boehringer Mannheim GmbH, Frankfurt,
Germany) using an enzyme/substrate ratio of 1:50
(w/w) in ammonium bicarbonate buffer pH 7.5 at
37uC; aliquotes taken at different times were
analysed.
Elution from the sensor chip
Elution from the sensor chip was performed
essentially as described by So ¨nksen et al. (So ¨nksen
et al., 1998)with the following modiﬁcations: 10 ml
of NH4HCO3 buffer pH 8 were used to elute most
of the bound PG. The elution was performed at the
beginning of the dissociation phase, without rinsing
the system. The eluted sample was subjected to
puriﬁcation from salts and preparation for MALDI
analysis by using reversed-phase nano-columns
prepared as described by Gobom et al. (Gobom
et al., 1999).
Mass spectrometry
MALDI mass spectra were acquired on a Voyager-
Elite MALDI-TOF (Applied Biosystems, MA)
mass spectrometer, operated in positive ion linear
mode.
Matrices used were 2,5-dihydroxybenzoic acid
(DHB) (Hewlett-Packard, Palo Alto,CA) 100 mLo f
100 mM solution lyophilised and redissolved in
an equal volume of 30% aqueous acetonitrile,
0.1% TFA and 4-hydroxy-a-cyanocinnaminic acid
(HCCA) (Sigma, St. Louis, MO) 10 mg/mL dissolved
in 70% aqueous acetonitrile, 0.1% TFA.
The spectra were externally calibrated by using
HP peptide standard (oxytocin, arginine-8-vaso-
pressin, angiotensin I, somatostatin, chicken atrial
natriuretic peptide (ANP), human r insulin, r
hirudin) (Hewlett-Packard, Palo Alto, CA).
Results and discussion
PG from F. moniliforme (FmPG) contains four
potential N-linked glycosylation sites (Caprari
et al., 1993). The enzyme used for this study is
FmPG expressed in Saccharomyces cerevisiae. When
analysed by SDS-PAGE, FmPG showed three
protein bands with molecular masses of 43, 46 and
50 kDa, respectively, corresponding to different
glycoforms of the same polypeptide chain (Caprari
et al., 1996). The calculated molecular mass of the
polypeptide is 36.2 kDa, indicating that the enzyme
puriﬁed from yeast is heavily glycosylated with a
carbohydrate content ranging from 16% in the
lightest glycoform to 28% in the heaviest one. As
shown in the MALDI spectrum of a glycopeptide
arising from the tryptic digest of PG, carbohydrate
microheterogeneity gives rise to multiple peaks with
mass differences corresponding to the carbohydrate
residues (Figure 1). Up to 14 Man residues are
present in the high-mannose type glycan chain
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Figure 2. A. Sensorgrams of the interaction between the
immobilised PGIP-2 and either native FmPG or FmPG
deglycosylated with EndoH. B. The deglycosylated FmPG
retained on the sensor surface is eluted and analysed by
MALDI-TOF-MS. The difference between the observed mass
(Mav=37110 Da) and the mass calculated for the polypep-
tide (36198 Da) is in good agreement with the presence of
four GlcNAc residues attached at the four potential
N-glycosylation sites. The peak at m/z 18556 corresponds
to the doubly charged ion of the protein
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whether the glycosylation of the enzyme is involved
in the binding of FmPG to PGIP-2, PG deglycosy-
lation was performed using endo-H, which leaves a
single GlcNAc residue present at each of the
occupied Asn residues. The enzymatic deglycosyla-
tion does not affect the proper folding of the
enzyme which maintains activity and produces an
oligogalacturonide proﬁle comparable to that pro-
duced by the wild type enzyme (Bergmann et al.,
1996). Native PG and PG treated with endo-H were
passed over a sensor chip with immobilised PGIP-2
(Figure 2). The sensorgram in Figure 2A shows that
the deglycosylated enzyme binds to the inhibitor.
Interestingly, the afﬁnity for the deglycosylated
enzyme is higher than that of the glycosylated
form, with a difference in the equilibrium response
of ca. 1000 RU. We concluded that not only the
glycosylation of FmPG is not required for binding
to PGIP, but also that the presence of the glycans
might sterically reduce the number of contacts
between the two proteins.
A modiﬁcation of the method developed by
So ¨nksen et al., (1998) was used for the recovery of
the afﬁnity-bound enzyme from the sensor surface
for mass spectrometric analysis (Figure 2B). The
amount of protein eluted from the sensor chip was
calculated to be ca. 40 fmol, as based on the
molecular weight of PG. The protein eluted from
the sensor surface showed an average molecular
mass of 37110 Da, in good agreement with the mass
calculated for the polypeptide (36198 Da) plus four
GlcNAc residues attached at the four potential
N-glycosylation sites.
In order to locate the domain of PG recognised
by the inhibitor, a peptide mixture was prepared by
limited proteolysis of the native enzyme with
Endoproteinase Lys-C (Figure 3). The peptide
mixture derived by treatment with Endoproteinase
Lys-C was passed in ﬂow over the sensor surface
with immobilised PGIP-2, and over a reference
ﬂow-cell as a control. One peptide with m/z 6479.9
was speciﬁcally recovered from the ﬂow-cell with
immobilised PGIP-2 (Figure 3B). In addition to the
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Figure 3. A. MALDI spectrum of the peptide mixture obtained by the digestion of native FmPG with endoproteinase LysC.
The mixture was injected in the BIACORE and passed over a sensor chip with immobilised PGIP and over a reference ﬂow-
cell as a control; B. MALDI spectrum of the sample eluted from the PGIP surface. The ion at m/z 6479.9 corresponds to the
peptide comprising the residues 181–244; C. MALDI spectrum of the sample eluted from the reference ﬂow-cell. The ion at
m/z 4818.6, present also in spectrum B, is a contaminant frequently observed after elution
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4818.6, also present in the fraction eluted from the
reference ﬂow-cell, was detected (Figure 3B and C).
The last peak is not present in the original mixture
of peptides (Figure 3A) and is probably a contami-
nant that comes from the elution procedure. The
peak at m/z 6479.9 corresponds to the PG fragment
spanning from amino acid 181 to amino acid 244
comprising several residues of FmPG which are
conserved in all the known fungal PGs and form
the active site of this class of enzymes (Armand
et al., 2000). Among them Asp191, Asp212, Asp213
correspond to residues that in PGII from Aspergil-
lus niger (AnPGII) have been shown to be involved
in catalysis, and His 234 corresponds to a residue
that in AnPGII is thought to play an indirect role
in catalysis (Armand et al., 2000). Recently we
reported the crystal structure of FmPG, that
allows us to locate the peptide 181–244 within the
putative active site cleft of the enzyme (Figure 4).
By site-directed mutagenesis and SPR analysis, we
have demonstrated that several amino acids of the
active site and His188, at the edge of the active site
cleft, are critical for the formation of the complex
with PGIP (Federici et al., 2001). Our isolation of
the peptide 181–244 which has a strong capacity of
interaction with PGIP-2, conﬁrms that most of the
residues critical for the interaction are located
within this region.
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